All In Biotech

Drug Trial Radar · NCT06908226

A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

A Phase 3, Open-Label Study to Investigate the Long-Term Safety and Efficacy of LP352 in the Treatment of Seizures in Children and Adults With Developmental and Epileptic Encephalopathy

Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

324

Planned (sponsor's estimate)

Start

Feb 12, 2025

Primary completion

Nov 11, 2027

Study completion Dec 17, 2027

Sponsor

Lead sponsor
Longboard PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Apr 3, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 66 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This (DEEp OLE Study) is a multicentre, open-label study to investigate the long-term safety, efficacy, tolerability, and pharmacokinetics (PK) of LP352 in the treatment of seizures in children and adults with DEE who completed Study LP352-301 or LP352-302. The study consists of 3 main phases: Screening, Titration period and Maintenance period, followed by a Taper period and Follow-Up. The total duration of the study will be approximately 14 months.

Conditions

  • Developmental and Epileptic Encephalopathy

Interventions

  • LP352Drug

    LP352 will be administered orally or through G-tube/ percutaneous endoscopic gastrostomy (PEG) tube.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants reporting Treatment emergent adverse events (TEAEs) and serious adverse events (SAEs) and AEs leading to discontinuationTime frame: Up to 61 Weeks
  2. Number of Participants With Clinically Significant Changes in Chemistry parametersTime frame: Up to 61 Weeks
  3. Number of Participants With Clinically Significant Changes in Hematology parametersTime frame: Up to 61 Weeks
  4. Number of Participants With Clinically Significant Changes in UrinalysisTime frame: Up to 61 Weeks
  5. Number of participants with clinically significant changes in vital signsTime frame: Up to 61 Weeks
  6. Number of participants with clinically significant changes in physical examinationsTime frame: Up to 61 Weeks
  7. Number of participants with clinically significant changes in growth parametersTime frame: Up to 61 Weeks
  8. Number of participants with clinically significant changes in electrocardiogram (ECG) parametersTime frame: Up to 61 Weeks
  9. Number of participants with postive responses to Columbia-Suicide Severity Rating Scale (C-SSRS)Time frame: Up to 61 Weeks
  10. Number of participants with positive responses to Patient Health Questionnaire-9 (PHQ-9) and Question 9Time frame: Up to 61 Weeks

Locations

88 sites in 17 countries. Site status is shown where the registry gives one.

  • Arkansas Children's Hospital - Cardiology Clinic

    Little Rock, Arkansas

  • University of California Los Angeles (UCLA) - David Geffen School of Medicine - Global Health Pro...

    Los Angeles, California

  • Stanford University - Stanford School of Medicine - Pulmonary and Cystic Fibrosis Center

    Palo Alto, California

  • UCSF Benioff Children's Hospitals - San Francisco

    San Francisco, California

  • Children's Hospital Colorado - Heart Institute

    Aurora, Colorado

  • NW FL Clinical Research Group, LLC

    Gulf Breeze, Florida

  • University of Miami Medical Group (UMMG)

    Miami, Florida

  • Research Institute of Orlando LLC

    Orlando, Florida

  • Pediatric Epilepsy & Neurology Specialists (PENS)

    Tampa, Florida

  • University of South Florida (USF) - Tampa Campus

    Tampa, Florida

  • Consultants in Epilepsy & Neurology, PLLC

    Boise, Idaho

  • University of Iowa Health Care Medical Center (University of Iowa Hospitals & Clinics)

    Iowa City, Iowa

  • Mid-Atlantic Epilepsy and Sleep Center - Bethesda

    Bethesda, Maryland

  • Massachusetts General Hospital (MGH)

    Boston, Massachusetts

  • Mayo Clinic - Children's Center - Rochester

    Rochester, Minnesota

  • Barnabas Health - Institute of Neurology and Neurosurgery

    Livingston, New Jersey

  • Northeast Regional Epilepsy Group - Morristown

    Morristown, New Jersey

  • NYU Langone Health-NYU Comprehensive Epilepsy Center

    New York, New York

  • Oregon Health & Science University - Blood Brain Barrier and Neuro-Oncology Program

    Portland, Oregon

  • Child Neurology Consultants of Austin - Austin

    Austin, Texas

  • The University of Texas Medical School at Houston - UT Gastroenterology

    Houston, Texas

  • Sydney Children's Hospital - Randwick

    Randwick, New South Wales, Australia

  • The Children's Hospital-Westmead - Heart Centre for Children

    Westmead, New South Wales, Australia

  • Royal Brisbane and Women's Hospital (RBWH)

    Brisbane, Queensland, Australia

  • Queensland Children's Hospital (Lady Cilento Children's Hospital)

    Brisbane, Queensland, Australia

  • Austin Hospital

    Heidelberg, Victoria, Australia

  • The Royal Children's Hospital (RCH) Melbourne

    Parkville, Victoria, Australia

  • Universitair Ziekenhuis Antwerpen (UZA)

    Edegem, Antwerp, Belgium

  • Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg

    Leuven, Flemish Brabant, Belgium

  • Universidade de Sao Paulo (USP) - Hospital das Clinicas da Faculdade de Medicina (HCFMUSP) - Inst...

    São Paulo, Brazil

  • Instituto de Neurologia de Curitiba (INC)

    Curitiba, Paraná, Brazil

  • Moinhos de Vento Hospital (Hospital Moinhos de Vento) (HMV)

    Porto Alegre, Rio Grande do Sul, Brazil

  • The Hospital for Sick Children (SickKids)

    Toronto, Ontario, Canada

  • Peking University First Hospital (Beida Hospital)

    Beijing, Beijing Municipality, China

  • Capital Medical University-Beijing Children's Hospital

    Beijing, Beijing Municipality, China

  • Guangzhou Medical University-The Second Affiliated Hospital

    Guangzhou, Guangdong, China

  • Shenzhen Children's Hospital

    Shenzhen Shi, Guangdong, China

  • Wuhan Children's Hospital

    Wuhan, Hubei, China

  • Fudan University - Children's Hospital

    Shanghai Shi, Shanghai Municipality, China

  • AP-HM- Hôpital de La Timone

    Marseille, France

Showing 40 of 88 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.